- The company’s affiliate, Vedanta Biosciences, has been awarded $5.8 million grant
- This grant is meant for the VE707 programme, which targets multi-drug resistant infections
- Vedanta Biosciences is eligible for $3.5 million in further funding on completion of pre-set targets
- Funds will be utilized for Vedanta's preclinical human microbiome-derived discovery programme
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.